Korea National Enterprise for Clinical Trials (KoNECT) has initiated the country's first decentralized clinical trial (DCT) pilot project, backed by a 4.5 billion won ($3.3 million) government investment over five years. The program, involving seven major medical institutions, will initially focus on approved drugs for mild conditions, allowing patients to participate in trials from home while maintaining regulatory compliance.